Computational Drug Discovery: Tools Across the Translational Pipeline

Feb 22–25, 2027 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Aicha BenTaieb and Jakob Kather

  Livestream
  In Person
  On Demand
 Add to Calendar
×

-

Feb 22–25, 2027 | Fairmont Banff Springs, Banff, AB, Canada

Scientific Organizers: Aicha BenTaieb and Jakob Kather

Supported by:  
Important Deadlines
Early Registration Deadline: December 28, 2026
Scholarship Deadline: November 24, 2026
Short Talk Abstract Deadline: November 24, 2026
Poster Abstract Deadline: February 2, 2027
Meeting Summary

Joint Meeting

This meeting runs jointly with Antibodies as Drugs: Evolving Designs, Formats, and Approaches.  

About This Meeting:

Recent advances in generative AI, large language models (LLMs), and multimodal learning are redefining what's possible in drug discovery. Yet significant translational challenges remain—from accurately identifying new targets to predicting therapeutic efficacy and safety in diverse patient populations. 

This Keystone Symposia conference on Computational Drug Discovery: Tools Across the Translational Pipeline will directly address the need to bridge these gaps by convening experts across machine learning, experimental biology, pharmacology, and clinical research. The meeting will follow the arc of drug discovery, with each day dedicated to a different phase of translation: Day 1 focuses on target discovery, highlighting computational models that decode molecular and cellular systems and validate perturbations using spatial, organoid, and real-world datasets. Day 2 covers drug design and preclinical development, featuring generative and simulation-based approaches for molecule design, pharmacokinetics, and dose optimization. Day 3 centers on clinical and real-world translation, showcasing multimodal learning from EHRs and clinical trials, digital biomarker discovery, and agentic AI systems for future-ready R&D. 

The program fosters collaboration between AI developers, biologists, translational scientists, and regulatory experts. Joint pairing with Antibodies as Drugs: Evolving Design, Formats and Approaches enables synergistic exchange between platform developers and computational toolmakers, bringing together disciplines that rarely converge within a single forum. 

Attendees will gain a clear, end-to-end view of how emerging computational methods are shifting traditional drug development paradigms—from iterative wet-lab cycles to predictive, simulation-driven pipelines. This integrated format offers an unmatched opportunity to shape the next generation of AI-driven drug discovery. 


Check out the speaker highlights in the video below:


Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates